Loading…
Based on limited metadata, BloVape, a tobacco product company, received an FDA Warning Letter on January 29, 2021, from the Center for Tobacco Products regarding violations of the Family Smoking Prevention and Tobacco Control Act. The violations appear to involve product adulteration and/or misbranding issues, though specific details cannot be confirmed without access to the full letter text. The warning falls under FDA's tobacco regulatory authority and the specific violations would have required the company to take corrective action to achieve compliance.